GSK Attempts to Stop The Rot And Maintain Market Share In China By Axing Employees
This article was originally published in PharmAsia News
Executive Summary
Acutely aware of a “bribery blacklist” that was supposed to be posted in March, but which has so far not appeared, scandal-hit GlaxoSmithKline is cleaning house by firing corruption-tainted China employees as it attempts to head off further sanctions.